It's official—AbbVie dumps Rova-T after another lung cancer fail - FierceBiotech

It's official—AbbVie dumps Rova-T after another lung cancer fail  FierceBiotech

Lung cancer patients taking Rova-T as a frontline treatment didn't live longer than those on placebo, prompting a data committee to recommend AbbVie halt the ...



Comments

Popular posts from this blog

Oncology: The disease, dynamics & challenges of market research

A Review of the Etiology and Epidemiology of Bladder Cancer: All ...

Lung Cancer Among People Who Never Smoked